Form D · Commercial
CAI Investments Medical Products I, DST
Las Vegas, NV · CIK 0001920781
Offering snapshot reported Apr 5, 2022 · SEC filing
- Reported sold
- Yet to sell Offering amount: $18.1M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.72M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-440309
Beneficial Interest in a Delaware Statutory Trust
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Emerson Equity LLC | 130032 |
Source: Form D, filed Apr 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Beavor | Executive |
| Cai Investments Llc | Executive |
Issuer details
Industry: Commercial (See others in industry)
Address:
9325 W. Sahara Ave.
Las Vegas, NV, 89117
Las Vegas, NV, 89117